Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$177M |
Are Zevra Therapeutics Insiders Buying or Selling?
Zevra Therapeutics (ZVRA) has had 2 insider transactions in the past 90 days, all sells. The most recent was Rahsaan Thompson, who sold 42,666 shares at $11.13 on August 14, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the ZVRA AI Score. For government officials trading this stock, see ZVRA congressional trading.
Who’s Trading Zevra Therapeutics Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Neil McFarlane | Sold $1.9M | 5 | Feb 9, 2026 |
| Rahsaan Thompson | Sold $1.2M | 5 | Aug 14, 2026 |
| Joshua Schafer | Sold $210,000 | 3 | Feb 3, 2026 |
| Alvin Shih | Bought $160,000 | 1 | Sep 12, 2025 |
| Watton Corey Michael | Sold $140,000 | 2 | Aug 10, 2026 |
| John Bode | Bought $130,000 | 2 | Aug 19, 2025 |
Recent Zevra Therapeutics Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Rahsaan Thompson | Aug 14, 2026 | Sell | 42,666 | $11.13 | $470,000 |
| Watton Corey Michael | Aug 10, 2026 | Sell | 12,300 | $11.25 | $140,000 |
| Rahsaan Thompson | Jun 22, 2026 | Sell | 34,557 | $12.68 | $440,000 |
| Rahsaan Thompson | May 11, 2026 | Sell | 1,794 | $11.3 | $20,000 |
| Neil McFarlane | Feb 9, 2026 | Sell | 14,625 | $8.56 | $130,000 |
| Joshua Schafer | Feb 3, 2026 | Sell | 10,500 | $9.19 | $97,000 |
| Timothy Sangiovanni | Feb 3, 2026 | Sell | 3,000 | $9.18 | $28,000 |
| Neil McFarlane | Feb 2, 2026 | Sell | 91,000 | $9.38 | $850,000 |
| Joshua Schafer | Jan 30, 2026 | Sell | 3,375 | $8.83 | $30,000 |
| Adrian Quartel | Jan 30, 2026 | Sell | 4,533 | $8.83 | $40,000 |
| Rahsaan Thompson | Jan 30, 2026 | Sell | 4,080 | $8.83 | $36,000 |
| Timothy Sangiovanni | Jan 30, 2026 | Sell | 1,750 | $8.82 | $15,000 |
| Neil McFarlane | Oct 10, 2025 | Sell | 19,500 | $10.82 | $210,000 |
| Alvin Shih | Sep 12, 2025 | Buy | 20,000 | $7.89 | $160,000 |
| TAMARA FAVORITO | Sep 12, 2025 | Buy | 3,175 | $7.79 | $25,000 |
| John Bode | Aug 19, 2025 | Buy | 5,000 | $9.17 | $46,000 |
| Rahsaan Thompson | Jun 26, 2025 | Sell | 24,000 | $9.21 | $220,000 |
| Watton Corey Michael | Mar 28, 2025 | Buy | 300 | $7.84 | $2,400 |
| John Bode | Mar 19, 2025 | Buy | 10,000 | $7.96 | $80,000 |
| Neil McFarlane | Feb 14, 2025 | Sell | 30,544 | $8.05 | $250,000 |
| Joshua Schafer | Feb 13, 2025 | Sell | 10,500 | $7.86 | $83,000 |
| Clifton R. LaDuane | Feb 13, 2025 | Sell | 11,000 | $7.86 | $86,000 |
| Neil McFarlane | Feb 13, 2025 | Sell | 61,273 | $7.86 | $480,000 |
| Timothy Sangiovanni | Feb 13, 2025 | Sell | 3,000 | $7.86 | $24,000 |
Frequently Asked Questions: Zevra Therapeutics Insider Trading
In the past 90 days, Zevra Therapeutics insiders have made 0 buys and 2 sells. The net selling may indicate insiders are taking profits or reducing exposure.
The most recent sale was by Rahsaan Thompson who sold 42,666 shares on August 14, 2026. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Shih Alvin has bought the most ZVRA stock in the last 2 years, with a total value of $160,000.
McFarlane Neil F. has sold the most ZVRA stock in the last 2 years, with a total value of $1.9M.
The total value of insider transactions for Zevra Therapeutics in the last 2 years is negative, amounting to -$3.3M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
